SCOPUS 정보 검색 플랫폼

Journal of Bone and Mineral Research

Volumn 20, Issue 8, 2005, Pages 1480-1481

Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?

(1) Api, Murat a

a HASEKI EDUCATION AND RESEARCH HOSPITAL (Turkey)

Author keywords

Alendronate; BMD; Fracture; Postmenopausal osteoporosis

Indexed keywords

ALENDRONIC ACID; PLACEBO;

ARTICLE; BONE DENSITOMETRY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FRAGILITY FRACTURE; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; MORPHOMETRICS; OUTCOMES RESEARCH; POSTMENOPAUSE OSTEOPOROSIS; RISK ASSESSMENT;

ALENDRONATE; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 22744447752 PISSN: 08840431 EISSN: None Source Type: Journal
DOI: 10.1359/JBMR.050504 Document Type: Article

Times cited : (2)

References (5)

1
- 12144289279
- Ten years' experience with alendronate for osteoporosis in postmenopausal women
- Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA 2004 Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189-1199.
- (2004) N Engl J Med , vol.350 , pp. 1189-1199
- Bone, H.G.¹ Hosking, D.² Devogelaer, J.P.³ Tucci, J.R.⁴ Emkey, R.D.⁵ Tonino, R.P.⁶ Rodriguez-Portales, J.A.⁷ Downs, R.W.⁸ Gupta, J.⁹ Santora, A.C.¹⁰ Liberman, U.A.¹¹

2
- 10244260283
- Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: Results from the National Osteoporosis Risk Assessment (NORA)
- Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA 2004 Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: Results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res 19:1215-1220.
- (2004) J Bone Miner Res , vol.19 , pp. 1215-1220
- Siris, E.S.¹ Brenneman, S.K.² Miller, P.D.³ Barrett-Connor, E.⁴ Chen, Y.T.⁵ Sherwood, L.M.⁶ Abbott, T.A.⁷

3
- 0035055470
- Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility
- Bolotin HH, Sievanen H 2001 Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility. J Bone Miner Res 16:799-805.
- (2001) J Bone Miner Res , vol.16 , pp. 799-805
- Bolotin, H.H.¹ Sievanen, H.²

4
- 4444255602
- Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis
- Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr 2004 Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J Am Geriatr Soc 52:1543-1548.
- (2004) J Am Geriatr Soc , vol.52 , pp. 1543-1548
- Silverman, S.L.¹ Delmas, P.D.² Kulkarni, P.M.³ Stock, J.L.⁴ Wong, M.⁵ Plouffe Jr., L.⁶

5
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group
- Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443.
- (1995) N Engl J Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³ Minne, H.W.⁴ Quan, H.⁵ Bell, N.H.⁶ Rodriguez-Portales, J.⁷ Downs Jr., R.W.⁸ Dequeker, J.⁹ Favus, M.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.